Daptomycin vs Teixobactin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Daptomycin (Cubicin) is a cyclic lipopeptide antibiotic from Streptomyces roseosporus, FDA-approved in 2003. It has a novel mechanism of action distinct from all other approved antibiotics: calcium-dependent insertion into bacterial membranes followed by channel formation and rap...
Calculate Daptomycin dose →Teixobactin was reported in Nature in 2015 as the first new antibiotic class discovered in 30 years, isolated from uncultured soil bacteria Eleftheria terrae using the iChip (isolation chip) technology that allows cultivation of previously unculturable organisms. Teixobactin bind...
Calculate Teixobactin dose →| Parameter | Daptomycin | Teixobactin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | Preclinical |
| Half-Life | 8-9 hours | Hours (in vivo) |
| Typical Dose | 4-6 mg/kg IV once daily (skin); 6-10 mg/kg IV once daily (bacteremia) | N/A |
| Frequency | Once daily IV | N/A |
| Route | IV | Research only (IV in animal studies) |
| FDA Status | Approved (MRSA skin, bacteremia, right-sided endocarditis, 2003) | Not approved (preclinical) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.